Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 32

Sort by

Sort Order Select

Journal Articles

Health-related quality of life (HRQoL) in patients with newly diagnosed multiple myeloma (NDMM) eligible for transplantation and treated with isatuximab, lenalidomide, bortezomib, and dexamethasone (Isa-RVd) versus rvd alone: Results from part 1 of the GMMG-HD7 study

Blood (2025) 146 (Supplement 1): 2263.

https://doi.org/10.1182/blood-2025-2263

Published: 2025

Journal Articles

Shifting first-line paradigms: Real-world treatment outcomes and healthcare burden in non-transplant newly diagnosed multiple myeloma in France (2015-2022)

Feng Lin, Peggy Lin, Giancarlo Pesce, Raissa Kapnang, Nadia Quignot, Lea Antoniali, Tilia Soubbotine, Xavier Leleu

Blood (2025) 146 (Supplement 1): 6353.

https://doi.org/10.1182/blood-2025-6353

Published: 2025

Journal Articles

Real-world treatment patterns and outcomes in frail and non-frail patients with newly diagnosed multiple myeloma not undergoing frontline transplant: A study using cota oncology database

Feng Lin, Samy Gallienne, Raluca Ionescu-Ittu, Yvonne Barnes, Joshua Richter

Blood (2025) 146 (Supplement 1): 6352.

https://doi.org/10.1182/blood-2025-6352

Published: 2025

Journal Articles

Health-Related Quality of Life (HRQoL) in Patients with Newly Diagnosed Multiple Myeloma (NDMM) Ineligible for Transplantation and Treated with Isatuximab, Bortezomib, Lenalidomide, and Dexamethasone (Isa-VRd) Vs. Vrd Alone: Results from the Imroz Study

Blood (2024) 144 (Supplement 1): 3352.

https://doi.org/10.1182/blood-2024-207087

Published: 2024

Journal Articles

Understanding Frontline Therapy Pattern, Attrition Rates and Survival Outcomes in Patients with Newly Diagnosed Multiple Myeloma Who Underwent Transplant

Feng Lin, Samy Gallienne, Raluca Ionescu-Ittu, Medha Sasane, Ani Minasyan, Christina Tekle, Joshua Richter

Blood (2024) 144 (Supplement 1): 3761.

https://doi.org/10.1182/blood-2024-201296

Published: 2024

Journal Articles

Frontline Treatment Patterns and Outcomes in Patients with Newly Diagnosed Multiple Myeloma Who Did Not Undergo Transplant: A US Electronic Health Records Database Analysis

Feng Lin, Samy Gallienne, Raluca Ionescu-Ittu, Medha Sasane, Ani Minasyan, Christina Tekle, Joshua Richter

Blood (2024) 144 (Supplement 1): 5138.

https://doi.org/10.1182/blood-2024-201260

Published: 2024

Journal Articles

A Novel Aggressive NK Cell Leukemia Cell Line and Mouse Model for Evaluation of Therapeutic Candidates

Xiaoxian Zhao, Caroline Astbury, Feng Lin, Darren C. Phillips, Eric D. Hsi

Blood (2021) 138 (Supplement 1): 1198.

https://doi.org/10.1182/blood-2021-146645

Published: 2021

Journal Articles

CD6-Targeted Antibody-Drug Conjugate As a Potential Therapeutic Agent for T Cell Lymphomas

Neetha Parameswaran, Liping Luo, Lingjun Zhang, Joel Chen, David A Fox, Eric D. Hsi, Deepa Jagadeesh, Feng Lin

Blood (2021) 138 (Supplement 1): 1193.

https://doi.org/10.1182/blood-2021-146855

Published: 2021

Journal Articles

A CD6-Targeted Antibody-Drug Conjugate As a Potential Therapy for T Cell-Mediated Disorders

Linjun Zhang, Liping Luo, Joel Chen, Rupesh Singh, William Baldwin, David A Fox, Daniel Lindner, Feng Lin

Blood (2021) 138 (Supplement 1): 3817.

https://doi.org/10.1182/blood-2021-145449

Published: 2021

Journal Articles

Inducible caspase-9 suicide gene controls adverse effects from alloreplete T cells after haploidentical stem cell transplantation

Xiaoou Zhou, Gianpietro Dotti, Robert A. Krance, Caridad A. Martinez, Swati Naik, Rammurti T. Kamble, April G. Durett, Olga Dakhova, Barbara Savoldo, Antonio Di Stasi, David M. Spencer, Yu-Feng Lin, Hao Liu, Bambi J. Grilley, Adrian P. Gee, Cliona M. Rooney, Helen E. Heslop, Malcolm K. Brenner

Blood (2015) 125 (26): 4103–4113.

https://doi.org/10.1182/blood-2015-02-628354

Published: 2015

Includes: Supplemental data

Journal Articles

Long-term outcome after haploidentical stem cell transplant and infusion of T cells expressing the inducible caspase 9 safety transgene

Xiaoou Zhou, Antonio Di Stasi, Siok-Keen Tey, Robert A. Krance, Caridad Martinez, Kathryn S. Leung, April G. Durett, Meng-Fen Wu, Hao Liu, Ann M. Leen, Barbara Savoldo, Yu-Feng Lin, Bambi J. Grilley, Adrian P. Gee, David M. Spencer, Cliona M. Rooney, Helen E. Heslop, Malcolm K. Brenner, Gianpietro Dotti

Blood (2014) 123 (25): 3895–3905.

https://doi.org/10.1182/blood-2014-01-551671

Published: 2014

Includes: Supplemental data

Journal Articles

The role of complement component 3 (C3) in differentiation of myeloid-derived suppressor cells

Ching-Chuan Hsieh, Hong-Shiue Chou, Horng-Ren Yang, Feng Lin, Sumantha Bhatt, Jie Qin, Lianfu Wang, John J. Fung, Shiguang Qian, Lina Lu

Blood (2013) 121 (10): 1760–1768.

https://doi.org/10.1182/blood-2012-06-440214

Published: 2013

Includes: Supplemental data

Journal Articles

Hepatic Stellate Cell Conditioned Myeloid Cells Provide a Novel Therapy for Prevention of Factor VIII Antibody Formation in the Hemophilia A Mouse Model

Sumantha Bhatt, Kathleen Brown, Feng Lin, Ph.D., Michael P Meyer, Margaret V. Ragni, MD, MPH, Lina Lu, Ph.D.

Blood (2012) 120 (21): 4117.

https://doi.org/10.1182/blood.V120.21.4117.4117

Published: 2012

Journal Articles

Mesenchymal stem cells are injured by complement after their contact with serum

Yan Li, Feng Lin

Blood (2012) 120 (17): 3436–3443.

https://doi.org/10.1182/blood-2012-03-420612

Published: 2012

Includes: Supplemental data

Journal Articles

Hypoxia-Inducible Factor 1-Mediated Human GATA1 Induction Promotes Erythroid Differentiation Under Hypoxic Conditions

Jun-Wu Zhang, Ph. D, Feng-Lin Zhang, Ph. D, Guo-Min Shen, Ph. D, Xiao-Ling Liu, Ph.D, Fang Wang, Ph. D

Blood (2011) 118 (21): 4794.

https://doi.org/10.1182/blood.V118.21.4794.4794

Published: 2011

Journal Articles

The identification and characterization of zebrafish hematopoietic stem cells

Dongdong Ma, Jing Zhang, Hui-feng Lin, Joseph Italiano, Robert I. Handin

Blood (2011) 118 (2): 289–297.

https://doi.org/10.1182/blood-2010-12-327403

Published: 2011

Journal Articles

Efficient osteoclast differentiation requires local complement activation

Zhidan Tu, Hong Bu, James E. Dennis, Feng Lin

Blood (2010) 116 (22): 4456–4463.

https://doi.org/10.1182/blood-2010-01-263590

Published: 2010

Journal Articles

Establishment of the first World Health Organization International Genetic Reference Panel for quantitation of BCR-ABL mRNA

Blood (2010) 116 (22): e111–e117.

https://doi.org/10.1182/blood-2010-06-291641

Published: 2010

Includes: Supplemental data

Journal Articles

Harmonized Testing for BCR-ABL Kinase Domain Mutations In CML: Results of a Survey and First Control Round within 28 National Reference Laboratories In Europe

Blood (2010) 116 (21): 894.

https://doi.org/10.1182/blood.V116.21.894.894

Published: 2010

Journal Articles

Adverse Events Following Infusion of T Cells for Adoptive Immunotherapy: A 10 Year Experience.

Conrad Russell Y. Cruz, MD, Patrick Hanley, Hao Liu, PhD, Vicky Torrano, Yu-Feng Lin, Stephen Gottschalk, MD, Barbara Savoldo, MD, PhD, Gianpietro Dotti, MD, Chrystal Louis, M.D., Ann M. Leen, PhD, Cliona M. Rooney, PhD, Adrian P. Gee, PhD, Malcolm K. Brenner, MB, PhD, FRCP, FRCPath, Catherine M. Bollard, MD, FRACP, FRCPA, Helen E. Heslop, MD

Blood (2009) 114 (22): 3212.

https://doi.org/10.1182/blood.V114.22.3212.3212

Published: 2009

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Health-related quality of life (HRQoL) in patients with newly diagnosed multiple myeloma (NDMM) eligible for transplantation and treated with isatuximab, lenalidomide, bortezomib, and dexamethasone (Isa-RVd) versus rvd alone: Results from part 1 of the GMMG-HD7 study

Shifting first-line paradigms: Real-world treatment outcomes and healthcare burden in non-transplant newly diagnosed multiple myeloma in France (2015-2022)

Real-world treatment patterns and outcomes in frail and non-frail patients with newly diagnosed multiple myeloma not undergoing frontline transplant: A study using cota oncology database

Health-Related Quality of Life (HRQoL) in Patients with Newly Diagnosed Multiple Myeloma (NDMM) Ineligible for Transplantation and Treated with Isatuximab, Bortezomib, Lenalidomide, and Dexamethasone (Isa-VRd) Vs. Vrd Alone: Results from the Imroz Study

Understanding Frontline Therapy Pattern, Attrition Rates and Survival Outcomes in Patients with Newly Diagnosed Multiple Myeloma Who Underwent Transplant

Frontline Treatment Patterns and Outcomes in Patients with Newly Diagnosed Multiple Myeloma Who Did Not Undergo Transplant: A US Electronic Health Records Database Analysis

A Novel Aggressive NK Cell Leukemia Cell Line and Mouse Model for Evaluation of Therapeutic Candidates

CD6-Targeted Antibody-Drug Conjugate As a Potential Therapeutic Agent for T Cell Lymphomas

A CD6-Targeted Antibody-Drug Conjugate As a Potential Therapy for T Cell-Mediated Disorders

Inducible caspase-9 suicide gene controls adverse effects from alloreplete T cells after haploidentical stem cell transplantation

Long-term outcome after haploidentical stem cell transplant and infusion of T cells expressing the inducible caspase 9 safety transgene

The role of complement component 3 (C3) in differentiation of myeloid-derived suppressor cells

Hepatic Stellate Cell Conditioned Myeloid Cells Provide a Novel Therapy for Prevention of Factor VIII Antibody Formation in the Hemophilia A Mouse Model

Mesenchymal stem cells are injured by complement after their contact with serum

Hypoxia-Inducible Factor 1-Mediated Human GATA1 Induction Promotes Erythroid Differentiation Under Hypoxic Conditions

The identification and characterization of zebrafish hematopoietic stem cells

Efficient osteoclast differentiation requires local complement activation

Establishment of the first World Health Organization International Genetic Reference Panel for quantitation of BCR-ABL mRNA

Harmonized Testing for BCR-ABL Kinase Domain Mutations In CML: Results of a Survey and First Control Round within 28 National Reference Laboratories In Europe

Adverse Events Following Infusion of T Cells for Adoptive Immunotherapy: A 10 Year Experience.

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only